Transmeta News

"We are disappointed with the slowdown in our third quarter revenues," said Dr. Matthew R. Perry, president and CEO of Transmeta. "The overall economic picture continued to constrain end-user spending on computing devices. Our results were affected by adjustments our customers made to their short-term forecasts late in the quarter," he said.

"However, design win activity gained momentum across many geographies in the third quarter. We began our first major shipments to China, and we gained new design wins with other Chinese customers. Interest in Crusoe is very strong in Taiwan, where we won numerous designs for our TM5800 and are seeing very strong interest in our next-generation processor. We also continued to win new designs in Japan," he said. "Customers everywhere tell us they are choosing Crusoe processors because they like the balance only we can provide of low maximum power, low cost, long battery life and high performance--in that order."

The company said that its first processor based on the next-generation 256-bit Crusoe architecture, the TM8000, remains on plan to ship in the third quarter of next year. "Customers are very excited about the value proposition this product offers over competing technologies. We are already in discussions with several potential customers regarding design-ins," Dr. Perry said.

"Our goal remains to be profitable by the fourth quarter of next year, as we believe we are well positioned with our new products and market focus to achieve growth in the second half of 2003," Dr. Perry said.

On November 7, Transmeta will join Microsoft and Hewlett-Packard in New York as Microsoft officially introduces the Windows XP Tablet PC Edition software, and as Hewlett-Packard debuts its HP Compaq Tablet PC, which is powered by Transmeta's 1-GHz Crusoe TM5800 processor. Later in the month, the company will be showcasing its technology at Comdex in Las Vegas. Transmeta's products will be featured both at its suites and at some of its customers' and partners' booths, including those of Microsoft, Hewlett-Packard and Antelope Technologies.

   Highlights:

   China

   --  Transmeta won new designs from Chinese customers in the third
       quarter. The company believes that China, with its rapidly
       growing electronics marketplace, is a key part of its
       geographic expansion strategy.

   --  SVA Group, a leading Chinese electronics manufacturer, is
       using Crusoe TM5800 processors in its new Classic Silver
       3.3-pound notebook computer. This is the second Crusoe-based
       product to be introduced in China, and will help to continue
       to increase Transmeta's presence in the fast-growing Chinese
       marketplace.

   Japan

   --  Transmeta's Crusoe processors continue to generate interest in
       Japan. In the third quarter, several customers designed the
       Crusoe TM5800 processor into their products.

   --  Sharp recently introduced its Mebius Muramasa mobile computer
       in Japan. Using the Crusoe TM5800 processor, this sub-notebook
       weighs only 950 grams.

   --  Sony introduced the autumn models of its VAIO C1 and VAIO U
       notebooks, which use Transmeta's Crusoe TM5800 processors.

   --  Fujitsu announced new models of its LOOX-T and LOOX-S mobile
       computers in Japan, which use Crusoe TM5800 processors.

   --  JMnet announced its Wake blade style compact server and Ultra
       PC-X board, which use Crusoe TM5800 processors.

   U.S.

   --  NEC Solutions America announced that its PowerMate eco(TM)
       desktop computer is now available in the U.S. The PowerMate
       eco, which won PC Magazine's Editor Choice award in October
       2002, uses the Crusoe TM5800 processor.

   --  Casio, Inc. recently introduced the Cassiopeia Fiva MPC-701
       series of pen tablet computers to the U.S. market. The pen
       tablets are powered by the Crusoe TM5800 processor and weigh
       only 3.1 pounds.

   Taiwan

   --  Transmeta gained significant traction into Taiwan-based
       products in Q3. Many customers incorporated the Crusoe TM5800
       processor into their designs and expressed very strong
       interest in the company's Crusoe TM8000 processor. Taiwan
       remains a very important region for Transmeta and the company
       expects momentum for its processors there to continue to grow.

   --  PaceBlade upgraded its three-in-one PC PaceBook, which uses
       the Crusoe TM5600 processor.

   Corporate

   --  Transmeta shipped its one millionth Crusoe processor.

   --  Microsoft Corporation certified Transmeta's Crusoe processors
       for the Windows CE .NET operating system, which enables
       Transmeta to attract new opportunities for mobile and embedded
       markets.

   --  Transmeta began shipping the Crusoe TM5800 System Development
       Kit that enables design engineers to quickly develop new
       mobile and embedded computing platforms using the Crusoe
       processor.

   Current Financial Outlook for Fourth Quarter 2002


The following outlook statements are based upon current expectations. These statements are forward looking, and actual results could differ materially.

Currently, the company expects that market demand in the fourth quarter will continue to be sluggish. Consequently, the company anticipates that its Q4 financial results will be as follows:

   --  Q4 2002 revenue is expected to be in the range of $5 million
       to $6 million.

   --  Pro forma net loss per share is expected to be $0.13 to $0.15.

   --  Operating expenses will remain flat at approximately $20
       million.

   --  Cash at the end of December should be approximately $129
       million after a scheduled $6 million payment to IBM in
       accordance with our technology license agreement.

   Conference Call


The company will hold a conference call at 2 p.m. Pacific Time today, October 16, 2002, to discuss the third quarter results. To participate, please dial (719) 457-2625 at approximately 1:50 p.m. A live webcast of the conference call will be available via the company's website at www.transmeta.com. A replay of the call will be available one hour after the completion of the call for one week. To access the recording, please dial 888 203-1112, passcode 361383. For callers outside the U.S., please dial 719 457-0820, with the same passcode.

   About Transmeta Corporation


Transmeta develops and sells software-based microprocessors and develops additional hardware and software technologies that enable computer manufacturers to build computers that simultaneously offer long battery life, high performance and x86 compatibility. Transmeta's family of Crusoe microprocessors is targeted at the notebook, Tablet PC and Internet appliance segments of the mobile Internet computer market, as well as a range of embedded applications.

   To learn more about Transmeta visit www.transmeta.com.

   Safe Harbor Statement


This release contains forward-looking statements regarding future events or the future financial performance of the company, which statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements are only predictions, which may differ materially from actual results or future events. All such forward-looking statements are based upon our current expectations but involve inherent risks and uncertainties. Such forward-looking statements speak only as of the date of this release, and the company will not necessarily provide updates of its forward-looking projections or forecasts. Risks and uncertainties that may have material effects on our future performance include general economic conditions, including the significant continuing slowdowns in the technology sector and semiconductor industry, the timing, rescheduling or cancellation of significant customer orders, potential fluctuations in our quarterly results, dependence on increasing demand for our Crusoe products, difficulties in developing or manufacturing new products in a timely and cost effective manner, market acceptance of our new products and of our customers' systems using our products, the growth of emerging markets, our customer concentration, the loss of revenue if a major customer were to cancel, reduce or delay a product order, inventory write-offs from a failure to forecast product demand accurately, our dependence on third parties for sourcing materials and providing manufacturing services, delays in product deliveries as we transition to smaller geometry process technologies, intense competition from Intel and others, rapid technological change, patents and intellectual property rights, volatility of our stock price, and the cyclical nature of the semiconductor market. We urge investors to review our regular filings with the Securities and Exchange Commission, including specifically our most recently filed reports on Form 10-K and 10-Q, which identify and describe many of these and other important risk factors that could cause our actual results to differ from those contained in these forward-looking statements.


                        TRANSMETA CORPORATION
                  PRO FORMA CONDENSED CONSOLIDATED
                      STATEMENTS OF OPERATIONS
              (In thousands, except per share amounts)

The following pro forma supplemental information excludes the
amortization of deferred charges and intangible assets, non-cash stock
compensation awards, in-process research and development, inventory
related charges, restructuring charges, and effects of previously
recorded inventory purchase commitments.


                           Three Months Ended     Nine Months Ended
                          --------------------- ---------------------
                           Sept. 27,  Sept. 28,  Sept. 27,  Sept. 28,
                              2002       2001       2002       2001
                          ----------- --------- ----------- ---------
                                (unaudited)           (unaudited)

Net revenue                    $6,443    $5,027     $18,129   $34,129
Cost of sales                   5,296     5,377      14,332    21,653
                          ----------- --------- ----------- ---------
Gross margin                    1,147      (350)      3,797    12,476
Operating expenses
 Research and development     13,707    17,029      50,971    51,388
 Selling, general and
  administrative               6,255     8,776      22,926    26,625
                          ----------- --------- ----------- ---------
      Total operating
       expenses               19,962    25,805      73,897    78,013
                          ----------- --------- ----------- ---------
Operating loss                (18,815)  (26,155)    (70,100)  (65,537)
 Interest and other, net       1,045     3,105       3,823    11,542
                          ----------- --------- ----------- ---------
Loss before provision
(benefit) for income taxes   (17,770)  (23,050)    (66,277)  (53,995)
 Provision (benefit) for
  income taxes                    (2)        5          23        22
                          ----------- --------- ----------- ---------
Net loss                     $(17,768) $(23,055)   $(66,300) $(54,017)
                          =========== ========= =========== =========

Net loss per share--basic
and diluted                   $(0.13)   $(0.18)     $(0.49)   $(0.42)

Weighted average shares
outstanding--basic and
diluted                       135,561   131,560     134,079   128,582

The pro forma amounts have been adjusted to
eliminate the following:

Stock compensation            $(1,651)   $4,046        $595   $15,823
Amortization of deferred
charges and
 intangible assets             2,848     5,024       8,544    12,512
Restructuring charges           4,102         -      14,726         -
In-process research and
development                        -         -           -    13,600
Excess inventory and
purchase commitment
charge                       $(1,302)  $(2,540)    $(1,885)  $25,591


                        TRANSMETA CORPORATION
                       CONDENSED CONSOLIDATED
                      STATEMENTS OF OPERATIONS
              (In thousands, except per share amounts)


                          Three Months Ended     Nine Months Ended
                         --------------------- ----------------------
                           Sept. 27,  Sept. 28,  Sept. 27,  Sept. 28,
                             2002       2001       2002       2001
                         ----------- --------- ----------- ----------
                               (unaudited)           (unaudited)

Net revenue                   $6,443    $5,027     $18,129    $34,129
Cost of sales                  3,994     2,837      12,447     47,244
                         ----------- --------- ----------- ----------
Gross margin                   2,449     2,190       5,682    (13,115)
Operating expenses
 Research and development    13,707    17,029      50,971     51,388
 In-process research and
  development                     -         -           -     13,600
 Selling, general and
  administrative              6,255     8,776      22,926     26,625
 Restructuring charges        4,102         -      14,726          -
 Amortization of deferred
  charges and intangible
  assets                      2,848     5,024       8,544     12,512
 Stock compensation          (1,651)    4,046         595     15,823
                         ----------- --------- ----------- ----------
    Total operating
     expenses                25,261    34,875      97,762    119,948
                         ----------- --------- ----------- ----------
Operating loss               (22,812)  (32,685)    (92,080)  (133,063)
 Interest and other, net      1,045     3,105       3,823     11,542
                         ----------- --------- ----------- ----------
Loss before provision
(benefit) for income
taxes                       (21,767)  (29,580)    (88,257)  (121,521)
 Provision (benefit) for
  income taxes                   (2)        5          23         22
                         ----------- --------- ----------- ----------
Net loss                    $(21,765) $(29,585)   $(88,280) $(121,543)
                         =========== ========= =========== ==========

Net loss per share--basic
and diluted                  $(0.16)   $(0.22)     $(0.66)    $(0.95)

Weighted average shares
 outstanding--basic and
  diluted                   135,561   131,560     134,079    128,582


                        TRANSMETA CORPORATION
                CONDENSED CONSOLIDATED BALANCE SHEETS
                           (In thousands)


                                                Sept. 27,   Dec. 28,
                                                   2002     2001 (1)
                                               ----------- ---------
Assets                                          (unaudited)
Current assets
 Cash and short-term investments                 $155,751  $241,688
 Accounts receivable, net                           4,082     1,749
 Inventories                                        8,329     1,388
 Prepaid and other current assets                   3,546     7,091
                                               ----------- ---------
    Total current assets                          171,708   251,916
Property and equipment, net                          8,790    11,622
Other assets                                        40,330    45,486
                                               ----------- ---------
    Total assets                                 $220,828  $309,024
                                               =========== =========

Liabilities and Stockholders' Equity
Current liabilities
 Accounts payable and other current liabilities   $11,739   $17,103
 Current portion of accrued restructuring costs     2,964         -
 Current portion of long-term obligations          15,640    17,661
                                               ----------- ---------
    Total current liabilities                      30,343    34,764
Long-term accrued restructuring costs                5,947         -
Long-term payables                                  23,313    29,295
Stockholders' equity                               161,225   244,965
                                               ----------- ---------
    Total liabilities and stockholders' equity   $220,828  $309,024
                                               =========== =========


(1) Derived from audited financial statements included in the
Company's Form 10-K for the fiscal year 2001 filed with the Securities
and Exchange Commission.


CONTACT: Transmeta Corporation
S. Olav Carlsen, 408/919-3000
or
Stapleton Communications Inc.
Deborah Stapleton, 650/470-0200


 

Heute satte 46% im Plus.

um über 15%. Kann allerdings keine News dazu finden.

Nicht schlecht.

Chiphersteller Transmeta mit Quartalszahlen
16.01.2003 22:21:00


   
Der Chiphersteller Transmeta, der hauptsächlich Prozessoren für mobile Geräte wie Laptops produziert, meldete heute die Zahlen für das vierte Quartal 2002. Den Angaben zufolge fiel bei einem Umsatz von 6,1 Mio. Dollar ein Verlust von 21,7 Mio. Dollar an. Exklusive Abschreibungen lag das Minus allerdings nur bei 17,6 Mio. Dollar oder 13 Cents je Aktie. Dieses Ergebnis entspricht nahezu dem des Vorquartals.
Analysten hatten im Vorfeld einen Verlust von 13 Cents je Aktie bei Erlösen in Höhe von 5 Mio. Dollar erwartet.

Das Management kündigte an, vor allem in der zweiten Jahreshälfte 2003 deutlich wachsen zu können, da dann der Chip TM8000 in größeren Mengen verkauft werden könnte. Dies hänge mit einer steigenden Nachfrage nach Tablet-PCs zusammen, die immer beliebter würden.

Für das erste Quartal rechnet Transmeta allerdings mit Umsätzen auf dem Niveau des vierten Quartals. Der Verlust soll bei 12-13 Cents je Aktie liegen.

Nachbörslich konnte die Aktie zwei Prozent auf 1,40 Dollar zulegen.
 

Bisher keine News gefunden.

Laut den Analysten von Pacific Growth hat Transmeta einen Auftrag von Hewlett-Packard für seine Tablet PCs erhalten. Die Analysten versuchen aktuell, sich dies vom Unternehmen bestätigen zu lassen, hieß es. Sollte der Auftragseingang bestätigt werden, so würde dies die Wahrscheinlichkeit der Erreichung der Gewinnerwartungen im vierten Quartal Transmeta´s erhöhen, hieß es. Die Transmeta Aktie steigt um 18.49% auf $1.41.

Ich hatte auf einen kleinen Rücksetzer gehofft - leider nicht dabei.

Ist doch immer noch historisch günstig bewertet.
Durch Gewinnmitnahmen wird deine Gelegenheit noch kommen.

Transmeta verringert Verlust, steigert Umsatz
   
Der Chiphersteller Transmeta Corp. meldete am Donnerstag einen Anstieg seiner Umsätze.
Diese kletterten auf 6,0 Mio. Dollar von 4,1 Mio. Dollar im ersten Quartal des Vorjahres. Der Fehlbetrag lag bei 20,1 Mio. Dollar oder 15 Cents je Aktie nach einem Verlust von 30,9 Mio. Dollar oder 23 Cents je Aktie im Vorjahreszeitraum. Exklusive Sonderaufwendungen lag der Verlust bei 12 Cents je Aktie. Analysten erwarteten einen Verlust von 13 Cents je Aktie und einen Umsatz von 6,0 Mio. Dollar.

Im laufenden zweiten Quartal erwartet das Unternehmen einen Umsatz von 5,0 Mio. Dollar und einen Verlust von 13-14 Cents je Aktie.

Die Aktie schloss bei 1,04 Dollar und notiert nachbörslich bei 0,94 Dollar.

Transmeta gewinnt Hewlett-Packard als Kunden


Der Laptop-Prozessor-Anbieter Transmeta gibt bekannt, dass sein 1 GHz Crusoe TM5800 in Hewlett-Packard's HP Compaq Thin Client t5700 Notebook verwendet werden soll. Die Aktie wurde zuletzt bei $1.40 gehandelt

--------------------------------------------------

LAST MATCH
Price 1.4200
Time 9:02:00.728
TODAY'S ACTIVITY
Orders 186
Volume 105,413

CIAO

Transmeta mit neuem Vertragspartner in China



Der Chiphersteller Transmeta hat mit dem chinesischen Elektronikanbieter Chinese 2000 Holdings einen Vertrag zur Lieferung von Crusoe TM5800-Prozessoren geschlossen. Die stromsparenden CPUs sollen in Settop-Boxen, Notebooks und PCs unter Linux eingesetzt werden, gab das Unternehmen gestern in Santa Clara im US-Bundesstaat Kalifornien bekannt. Grundlage soll Midori Linux sein, Transmetas eigene Distribution für mobile Geräte.

Transmeta hat Anteile an dem chinesischen Unternehmen erworben, und plant die Herausgabe der Geräte in China, Hongkong, Macau und Taiwan. (as)  

  Transmeta Corp., einer der größten Intel-Konkurrenten im Bereich der mobilen PC-Prozessoren, hat heute einen neuen Kunden gewonnen. Die Plexus Corp., einer der größten Anbieter von Electronic Manufacturing Services, wird den TM5800 Prozessor von Transmeta zukünftig in eigene Produkte einbauen.
Vorteilhaft seien vor allem die energiesparenden Eigenschaften des TM5800, hieß es von Plexus. Finanzielle Einzelheiten des Deals wurden allerdings nicht bekannt.

Die Tramsmeta-Aktie reagierte dennoch mit einem Plus von 8 Prozent auf 1,47 Dollar.

 
-red- / -red-

Alpharma (ALO: news, chart, profile) leapt more than 7 percent after the generic-drug maker said it received final FDA approval for a version of Neurontin, Pfizer's epilepsy drug.

Atari (ATAR: news, chart, profile) shares added almost 5 percent after the company inked a licensing deal for Microsoft's (MSFT: news, chart, profile) Game Studios operations. The agreement calls for Atari to be the exclusive U.S. jewel case distributor for select Windows titles developed by Microsoft Game Studios. Financial terms of the deal, which runs through June 2006, weren't disclosed.

Boston Scientific (BSX: news, chart, profile) rose nearly percent after the company said its highly anticipated new cardiovascular stent dramatically reduced the rate of vessel reblockage among heart disease patients who received the device in late-stage clinical testing. The results appear to provide a boost to the medical device maker's bid to win U.S. regulatory clearance for the stent. Earlier, Boston Scientific said it expects third-quarter financial results to exceed previous projections. Shares of rival Johnson & Johnson (JNJ: news, chart, profile) slid almost 2 percent.

Brightpoint (CELL: news, chart, profile) rallied nearly 10 percent after the company said its board has declared a three-for-two split of its common stock. The split will be paid on Oct. 15 to shareholders of record on Sept. 30. Following the split, Brightpoint, a mobile phone distributor based in Plainfield, Ind., will have 18 million outstanding shares. The stock closed Friday at $27.50, up a nickel.

Shares of Curis (CRIS: news, chart, profile) jumped almost 9 percent after the company said its "Hedgehog" inhibitors helped block the growth of certain tumors, including high mortality pancreatic cancer. The Hedgehog signaling pathway is one of the mechanisms the human body uses to develop and maintain tissues and organs.

Elder-Beerman Stores (EBSC: news, chart, profile) surged almost 13 percent after the company said late Friday that it has received a $7.80 per share cash offer from privately held Wright Holdings, which tops the offer announced Thursday of $7.25 a share from Bon-Ton Stores (BONT: news, chart, profile). With about 11.5 million shares outstanding, the latest offer is worth about $89.9 million. The retail chain also said it amended a negotiating restriction in its previous accord with Wright so that it now can engage in negotiations with Bon-Ton. In exchange for that leeway, Elder-Beerman increased the potential breakup fee that would be paid to Wright by $500,000. Wright had begun the bidding war for Elder-Beerman in June with a $6 a share offer.

Endwave (ENWV: news, chart, profile) rose nearly 9 percent after the Sunnyvale, Calif., firm inked a deal to collaborate on the development of millimeter wave transceiver radio modules with Nokia (NOK: news, chart, profile). See full story.

Shares of Golden State Vintners (VINT: news, chart, profile) soared more than 44 percent after the company said late Friday that its board approved a plan to go private, assuming shareholders approve the deal in a November meeting. The plan includes a reverse stock split of one share for each 5,900 to concentrate company control. According to Hoover's, 65 percent of shares are controlled by Chairman Jeffrey Brown and several directors via SBIC Partners. The company said it expects director-controlled stock to total 80 percent of voting shares. Shareholders with fewer than 5,900 shares will receive $3.25 per share, a 56 percent premium to Friday's closing price of $2.08.

Labor Ready (LRW: news, chart, profile) tacked on almost 6 percent after the company raised its third-quarter earnings forecast to 21 to 23 cents a share from 18 to 20 cents a share, due to a rise in gross margins, coupled with continued cost controls. The provider of temporary labor also adjusted its revenue estimate to $250 million to $255 million from $245 million to $255 million.

Landstar System (LSTR: news, chart, profile) got a nearly 6 percent lift after Raymond James upgraded the trucking company to "strong buy" from "market perform," citing "several company specific business trends" which should be enhanced by a better economy. Analyst William Fisher noted that business capacity owner (BCO) count comparisons turned positive in July and August and believes that Landstar will benefit from any customer attrition resulting from the Roadway-Yellow merger. Fisher has a $75 price target on the stock.

Oglebay Norton (OGLE: news, chart, profile) shares rose almost 7 percent, building on a jump of nearly 100 percent on Friday when the stock ran to $2.90 from its Thursday close at $1.58. The buying interest was driven by news that the Cleveland-based minerals firm inked deals with its bank group and the holders of its senior secured notes to amend credit agreements and provide relief on restrictive financial covenants. This deal will restore Oglebay's ability to draw on its credit line to fund operations and make an interest payment on certain notes. Oglebay, whose minerals are used in building materials, plans to make the interest payment 'as soon as practicable.' The company also plans to hire Lazard Freres as its financial restructuring advisor.

Pumatech (PUMA: news, chart, profile) gained more than 7 percent after the San Jose, Calif., maker of data synchronization software agreed to acquire Synchrologic, a privately held rival based in Atlanta, Ga. The deal values Synchrologic at $60 million, and Pumatech expects the transaction to generate both operational savings and positive cash flow.

Transmeta shares (TMTA: news, chart, profile) climbed nearly 29 percent after the chipmaker said its Crusoe processors would be incorporated in two new Hewlett-Packard-Compaq "thin client" models, which are mobile computers without disk drives or CD-ROMs.

 

die nu endlich richtig rennen=)
thx4info
mfg kram

war nur ein bischen im Urlaub.
Sollte ich angesichts der Entwicklung der Nasdaq in der Zeit öfter machen.
Da verdient man ja mehr Geld als man im Urlaub ausgibt.

naja,tmta is für mich eh nich so kurzfristig...
seit ende mai zu 0.89€ dabei:)))

Nvidia schließt Allianz mit Transmeta
(©GodmodeTrader - www.godmode-trader.de)



Der Chiphersteller Transmeta und der Grafikchiphersteller Nvidia (WKN: 918422, US: NVDA) sind in eine Allianz eingetreten, innerhalb derer Nvidia integrierte Medien-Kommunikations-Prozessoren für die Nutzung in den Efficeon Prozessoren von Transmeta entwickeln wird. Der Efficeon Chip wird in Notebooks, Tablet PCs und anderen tragbaren Computing-Geräten zum Einsatz kommen.  

3,03 Dollar. Darf ruhig noch so weitergehen.

"We are working with Transmeta to enable their technology for the Transmeta Efficeon processor because it offers many features to improve computing performance," said Timothy D. Eades, Senior Vice President, Corporate Marketing and Products Division for Phoenix Technologies. "Faster processing and energy efficiency are becoming increasingly important. The streamlined north bridge design saves power and board space. In addition, the performance-to-power ratio is very competitive, supporting longer battery life for mobile users and more computing power for smaller devices."

"Transmeta and Phoenix have maintained a long-term strategic alliance because both companies are committed to addressing the market's needs for high performance, low-power, cool computing," said Dr. Matthew R. Perry, president and CEO, Transmeta Corporation. "By joining our technologies and core competencies with Phoenix's robust features and broad market reach, we will provide improved customer experiences for a full range of Transmeta processor-based systems, delivering enhanced reliability and security for servers, PCs and notebooks."

Dave Ditzel, the company's co-founder and chief technology officer, will make a presentation about the Transmeta Efficeon processor at Microprocessor Forum in San Jose, October 13-16, 2003. To learn more about Transmeta's Efficeon processor, visit www.efficeon.com.

About Transmeta Corporation

Transmeta Corporation develops and sells software-based microprocessors and develops additional hardware, software and system technologies that enable manufacturers to build highly efficient computing systems characterized by low power consumption, reduced heat dissipation and the high performance required to run standard x86 compatible programs. We originally developed our family of Crusoe microprocessors for lightweight notebook computers and other mobile computing devices, but we have developed and are continuing to develop microprocessors suitable for a variety of existing and emerging end markets in which x86 program compatibility and energy and thermal efficiency are desirable.

   To learn more about Transmeta, visit www.transmeta.com.

   About Phoenix cME and Phoenix cME FirstBIOS

Phoenix Core Managed Environment (cME) FirstBIOS is the third generation of core system software that gives manufacturers improved performance and powerful security for their devices. It delivers the compatibility and functionality that allows them to customize their products to a wide range of designs while improving their time to market. cME FirstBIOS is the foundation for Phoenix cME, an open software platform that enables the management and integration of functionality into the heart of digital devices. Applications and technologies such as utilities, productivity, security, and content delivery tools, can all be accessed independently and in support of the operating system from the cME platform. Both the cME platform and FirstBIOS solutions are available for PCs, servers, embedded systems and information appliances.

About Phoenix

Founded in 1979, Phoenix Technologies (Nasdaq:PTEC) helped launch the digital revolution when it created the industry's leading machine-independent BIOS software, which ships in more than 100 million new systems each year. Phoenix continues to leverage that core-level experience to develop many other vital solutions at multiple points in the foundation of PCs and other digital devices. Today, Phoenix solutions activate, secure, connect, and recover the world's best-known systems. These solutions operate from a Core Managed Environment (cME), where they're built in and protected from viruses, user errors, hackers, and corruption. Phoenix is headquartered in San Jose, Calif. USA (Silicon Valley), with offices in global business and technology centers. For more information about Phoenix Technologies, visit our website at www.phoenix.com.

Safe Harbor Statement

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include general economic and political conditions and specific conditions and volatility in the markets that we address, the rescheduling or cancellation of significant customer orders, market acceptance and adoption of our new products by our present and future customers and end users, difficulties in developing or manufacturing new and existing products in a timely and cost effective manner, our dependence on third parties for sourcing materials and providing manufacturing services, intense competition and competitive pressures, patents and other intellectual property rights, and other risk factors. We urge investors to review our filings with the Securities and Exchange Commission, including our most recent reports on Forms 10-K and 10-Q, which describe these and other important risk factors that could have an adverse effect on our results. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.

Transmeta, Efficeon, LongRun and Crusoe are trademarks of Transmeta Corporation. All other product or service names mentioned herein are the trademarks of their respective owners.

Phoenix and Phoenix Technologies are registered trademarks of Phoenix Technologies. All other trademarks are the property of their respective owners.

SOURCE: Transmeta Corporation

4,50 Schlusskurs. Not bad man.

Gruss E.

Den Prozessor positioniert Transmeta vor allem gegen Intels Pentium M. Statt mit maximalen Benchmarkwerten zu wuchern, gab Ditzel eine aus seiner Sicht für Mobile-Zwecke weit sinnvollere Performanceangabe an, und zwar Performance bei vorgegebener Maximalleistung (TDP). Hierfür legte er 7W TDP für Pentium-M und Efficeon zu Grunde. Bei dieser Vorgabe kann der Pentium M mit 900 MHz und Efficeon mit 1100 MHz laufen, wobei der Efficeon dann mit bis zu 2,7facher Performance (SHA1-Encryption) gegenüber seinem Konkurrenten zu glänzen vermag. Beim Linpack100 ist er in der 7-Watt-Disziplin 30 Prozent schneller. Auch bei System-Benchmarks wie SysMark 2002 liegt der Transmeta-Prozessor noch knapp um 13 Prozent in Front. Zusammen mit Nvidia Geforce4 420 go kann er gegen das Pentium-M/855GM-Gespann mit 2963 gegenüber 1819 auftrumpfen.

Besondere Aufmerksamkeit heimste Transmeta jedoch mit dem LongRun-2-Feature des Efficeon-Prozessors ein. Dynamisch die Kernspannung verringern -- das konnte schon das LongRun 1 des Crusoe. LongRun 2 kann jetzt jedoch mit "Software Controlled Leakage Management" auch dynamisch die Schwellenspannungen der Transistoren dem Bedarf anpassen, und zwar jeweils getrennt nach Transistortyp in n- oder p-Ausführung. Damit lassen sich die gefürchteten Leckströme, genauer das Threshold Leakage, massiv reduzieren. So verringert sich die Leckleistung im Standby-Modus von 144 mW auf 2 mW, also um mehr als den Faktor 70.

Longrun2 ist allerdings im Moment noch nicht ausreichend validiert, sodass es in den ersten Versionen nicht aktiviert ist. Das bleibt späteren Versionen vorbehalten. Mitte nächsten Jahres soll Efficeon bereits vom neuen Herstellungspartner Fujitsu auf 90-nm-Strukturen und eine Die-Größe von 68 mm? verkleinert gefertigt werden und dann die 2-GHz-Marke erreichen. Bei diesem Takt liegt der TDP dann bei 25 Watt -- für die 7-Watt-Benchmark-Marke darf er mit 1,6 GHz arbeiten.

Sharp, Fujitsu und Hewlett Packard gehören zu großen Firmen, die zum Launch des Prozessors ihren Support angekündigt haben, weitere sollen laut CEO Matthew R. Perry bald folgen. (as/c't)/ (tol[3]/c't)

die 4 Euro gefallen. Klasse